Zobrazeno 1 - 10
of 90
pro vyhledávání: '"V. Le Morvan"'
Autor:
Gaëlle Recher, N. Helaine, Céline Monvoisin, Laurence Bresson-Bepoldin, E. Dessauge, Kevin Alessandri, Frédéric Mourcin, Isabelle Mahouche, Céline Pangault, C. Lamaison, L. Broca-Brisson, Sylvain Latour, V. Le Morvan, Marine Seffals, Pierre Nassoy, Philippe Soubeyran, C. Dussert, Karin Tarte
Non-Hodgkin B-cell lymphomas (B-NHL) mainly develop within lymph nodes as densely packed aggregates of tumor cells and their surrounding microenvironment, creating a tumor niche specific to each lymphoma subtypes. Until now, in vitro preclinical mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5c1c19ac602953a462b6e9222d95c5c
https://hal.archives-ouvertes.fr/hal-03010816/document
https://hal.archives-ouvertes.fr/hal-03010816/document
Autor:
V Le Morvan, Frédéric Pinguet, S Ellis, A Massoubre, Etienne Chatelut, Melanie White-Koning, Fabienne Thomas, Isabelle Solassol, Litaty Mbatchi, N Tafzi, R Despax, H. Roche, N Levasseur, Jacques Robert, Alexandre Evrard, P Marquet
Publikováno v:
Cancer Research. 78:P3-12
Supported by a PHRC grant (#09-18-005) Background: Recent literature has suggested that germline genetic variants of drug-metabolizing enzymes or CYP19A1 (coding for aromatase) may be involved in the systemic aromatase inhibitors (AI) concentrations
Autor:
Cécile Arellano, J-C Boyer, Fabienne Thomas, Jacques Robert, Alexandre Evrard, Melanie White-Koning, H. Roche, P Houyau, A Puzskiel, J Dauba, Christelle Vachoux, M Poublanc, Etienne Chatelut, V Le Morvan
Publikováno v:
Cancer Research. 78:P3-12
Supported by a PHRC grant (#09-18-005) Background: The role of CYP2D6 genetic polymorphisms and plasma levels of active metabolites of tamoxifen (TAM) on clinical response and occurrence of side effects remains controversial. We conducted a prospecti
Autor:
S. Ait-Ouferoukh, Carlo Messina, R. Bellott, Hervé Bonnefoi, Saskia Litière, Jacques Robert, A. Laroche-Clary, David Cameron, V. Le Morvan
Publikováno v:
The Pharmacogenomics Journal. 15:63-68
Using cell line panels we identified associations between single-nucleotide polymorphisms (SNPs) and chemosensitivity. To validate these findings in clinics, we genotyped a subset of patients included in a neoadjuvant breast cancer trial to explore t
Autor:
V Le Morvan, Audrey Laroche-Clary, Jacques Robert, Jérôme Toutain, L Araud, Jun Kanno, Takao Yamori, N Faur
Publikováno v:
British Journal of Cancer
Background: We investigated, in the panel of 60 human tumour cell lines of the National Cancer Institute (NCI-60), whether the R72P polymorphism of TP53 and the T309G polymorphism of MDM2 were associated to the in vitro cytotoxicity of anticancer age
Publikováno v:
Bio Tribune Magazine. 21:76-85
Autor:
Philippe Pourquier, François Bertucci, Agnès Neuville, Sébastien Salas, Roberta Sanfilippo, Antoine Italiano, Vanessa Chaire, V. Le Morvan, Audrey Laroche-Clary
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2015, 112 (4), pp.688-692. ⟨10.1038/bjc.2014.624⟩
British Journal of Cancer, 2015, 112 (4), pp.688-692. ⟨10.1038/bjc.2014.624⟩
British Journal of Cancer, Cancer Research UK, 2015, 112 (4), pp.688-692. ⟨10.1038/bjc.2014.624⟩
British Journal of Cancer, 2015, 112 (4), pp.688-692. ⟨10.1038/bjc.2014.624⟩
International audience; BACKGROUND : This study aimed to determine whether the BRCA1 haplotype was associated with trabectedin efficacy in soft-tissue sarcoma (STS) patients.METHODS : We analysed BRCA1 single-nucleotide polymorphisms (SNPs) in tumour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a7951c8ca89b78c5f03c9cef713db76
https://www.hal.inserm.fr/inserm-02438840
https://www.hal.inserm.fr/inserm-02438840
Publikováno v:
British Journal of Cancer
Topoisomerase 1 (Top1), a nuclear enzyme involved in DNA relaxation, is the target of several anticancer drugs. TOP1 mutations occur in camptothecin-resistant tumour cell lines. We explored, in the NCI panel of 60 human tumour cell lines, whether pol
Publikováno v:
Oncologie. 7:7-16
Le sequencage du genome humain est a l’origine de la decouverte de millions de variations de sequence dans le genome humain. Ces variations de sequence d’ADN sont dans leur immense majorite limitees a des polymorphismes de nucleotide unique (Sing
Autor:
V. Le Morvan, J. Robert
Publikováno v:
Médecine personnalisée en cancérologie digestive ISBN: 9782817804262
Le sequencage du genome humain apporte de nouveaux outils pour l’individualisation de la chimiotherapie des cancers, d’abord grâce a l’identification de polymorphismes constitutionnels des genes impliques dans le metabolisme ou l’activite de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c37128f8563e4a3f0aa4903d50744aca
https://doi.org/10.1007/978-2-8178-0527-6_5
https://doi.org/10.1007/978-2-8178-0527-6_5